32 results
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
30 Mar 20
Processa Pharmaceuticals to Move Forward with a PCS499 Phase 3 Trial after a Successful Fda Meeting
4:00pm
ulcers in patients with NL. Processa initially planned to begin recruiting for this trial in Q4 2020 but with the COVID-19 pandemic, it is expected
8-K
EX-99.1
kf1qurbogx6uopn6o
13 May 21
Processa Pharmaceuticals Announces First Quarter 2021 Results and Provides Corporate Update
5:28pm
424B4
h6x0k
5 Oct 20
Prospectus supplement with pricing info
4:16pm
424B5
jukwdelb5v
20 Aug 21
Prospectus supplement for primary offering
4:46pm
PRE 14A
d27obetko
1 Sep 21
Preliminary proxy
4:46pm